HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,282,338 | +5.7% | 14,315 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $1,212,819 | -11.0% | 14,245 | -13.5% | 0.00% | 0.0% |
| Q1 2023 | $1,363,306 | +5.2% | 16,475 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,295,759 | -3.1% | 16,475 | -8.8% | 0.00% | 0.0% |
| Q3 2022 | $1,337,000 | +15.2% | 18,055 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $1,161,000 | +0.6% | 17,815 | -2.4% | 0.00% | +50.0% |
| Q1 2022 | $1,154,000 | +19.2% | 18,255 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $968,000 | -26.7% | 18,255 | -2.5% | 0.00% | -33.3% |
| Q3 2021 | $1,321,000 | +6.8% | 18,716 | +0.8% | 0.00% | +50.0% |
| Q2 2021 | $1,237,000 | -81.8% | 18,566 | -69.6% | 0.00% | -84.6% |
| Q1 2021 | $6,779,000 | -9.6% | 61,071 | -3.2% | 0.01% | -13.3% |
| Q4 2020 | $7,496,000 | +66.7% | 63,121 | +22.5% | 0.02% | +50.0% |
| Q3 2020 | $4,497,000 | +2.4% | 51,542 | +5.2% | 0.01% | -9.1% |
| Q2 2020 | $4,390,000 | +87.4% | 49,012 | +108.6% | 0.01% | +57.1% |
| Q1 2020 | $2,342,000 | -15.4% | 23,499 | -2.4% | 0.01% | 0.0% |
| Q4 2019 | $2,767,000 | -13.9% | 24,079 | -5.5% | 0.01% | -12.5% |
| Q3 2019 | $3,214,000 | +3.5% | 25,479 | -1.2% | 0.01% | 0.0% |
| Q2 2019 | $3,105,000 | +34.9% | 25,798 | -1.9% | 0.01% | +33.3% |
| Q1 2019 | $2,301,000 | -28.9% | 26,298 | -18.7% | 0.01% | -40.0% |
| Q4 2018 | $3,236,000 | -3.0% | 32,345 | +11.1% | 0.01% | +25.0% |
| Q3 2018 | $3,335,000 | +10.8% | 29,108 | -13.3% | 0.01% | 0.0% |
| Q2 2018 | $3,009,000 | +25.6% | 33,558 | +2.5% | 0.01% | +14.3% |
| Q1 2018 | $2,396,000 | +21.2% | 32,748 | -3.8% | 0.01% | +40.0% |
| Q4 2017 | $1,977,000 | +13.9% | 34,043 | -11.9% | 0.01% | 0.0% |
| Q3 2017 | $1,735,000 | +13.6% | 38,663 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $1,527,000 | -2.7% | 38,663 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $1,569,000 | +1.0% | 38,663 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $1,554,000 | +1.4% | 38,663 | -8.6% | 0.01% | 0.0% |
| Q3 2016 | $1,533,000 | +23.0% | 42,323 | -1.6% | 0.01% | +25.0% |
| Q2 2016 | $1,246,000 | -18.1% | 42,993 | -1.1% | 0.00% | -33.3% |
| Q1 2016 | $1,521,000 | +8.5% | 43,476 | 0.0% | 0.01% | +20.0% |
| Q4 2015 | $1,402,000 | -0.2% | 43,476 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $1,405,000 | -21.9% | 43,476 | 0.0% | 0.01% | -16.7% |
| Q2 2015 | $1,798,000 | -7.9% | 43,476 | 0.0% | 0.01% | -14.3% |
| Q1 2015 | $1,953,000 | +20.4% | 43,476 | +0.3% | 0.01% | +40.0% |
| Q4 2014 | $1,622,000 | +6.9% | 43,336 | -0.3% | 0.01% | 0.0% |
| Q3 2014 | $1,518,000 | -2.7% | 43,467 | -1.7% | 0.01% | 0.0% |
| Q2 2014 | $1,560,000 | +8.3% | 44,227 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $1,441,000 | -22.7% | 44,227 | 0.0% | 0.01% | -16.7% |
| Q4 2013 | $1,863,000 | +2.8% | 44,227 | -2.7% | 0.01% | 0.0% |
| Q3 2013 | $1,813,000 | -3.6% | 45,466 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $1,880,000 | – | 45,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |